oxybutynin has been researched along with Excessive Periodic Sleep-Related Leg Movements in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with moderate to severe restless legs syndrome (RLS) were randomized to rotigotine (optimal dose [1-3 mg/24 h]) or placebo." | 2.82 | Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT. ( Bauer, A; Bauer, L; Benes, H; Carney, HC; Cassel, W; Grieger, F; Joeres, L; Kesper, K; Moran, K; Oertel, W; Rye, D; Schollmayer, E; Sica, D; Trenkwalder, C; Walters, AS; Whitesides, J; Winkelman, JW, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liguori, C | 1 |
| Placidi, F | 1 |
| Stefani, A | 1 |
| Mercuri, NB | 1 |
| Marciani, MG | 1 |
| Stanzione, P | 1 |
| Pierantozzi, M | 1 |
| Bauer, A | 1 |
| Cassel, W | 1 |
| Benes, H | 1 |
| Kesper, K | 1 |
| Rye, D | 1 |
| Sica, D | 1 |
| Winkelman, JW | 1 |
| Bauer, L | 1 |
| Grieger, F | 1 |
| Joeres, L | 1 |
| Moran, K | 1 |
| Schollmayer, E | 1 |
| Whitesides, J | 1 |
| Carney, HC | 1 |
| Walters, AS | 1 |
| Oertel, W | 1 |
| Trenkwalder, C | 1 |
1 trial available for oxybutynin and Excessive Periodic Sleep-Related Leg Movements
| Article | Year |
|---|---|
Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.
Topics: Adolescent; Adult; Aged; Blood Pressure; Blood Pressure Determination; Dopamine Agonists; Double-Bli | 2016 |
1 other study available for oxybutynin and Excessive Periodic Sleep-Related Leg Movements
| Article | Year |
|---|---|
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder.
Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Pa | 2015 |